News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Wael Abdulla Moh Khair, MD

Articles by Wael Abdulla Moh Khair, MD

PET-adapted strategies enhance treatment for advanced classical Hodgkin lymphoma, optimizing outcomes through individualized escalation and de-escalation based on PET results.

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era

ByWael Abdulla Moh Khair, MD

October 26th 2025

Latest Updated Articles

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
Published: October 26th 2025 | Updated:

Trending on CancerNetwork

Sacituzumab Govitecan Does Not Meet Statistical Significance in HR+/HER2– mBC

Frontline Giredestrant Displays IDFS Improvement vs SOC ET in ER+/HER2– BC

Resecting MRI-Detected Disease Doesn’t Improve Outcomes in Early-Stage BC

Pembrolizumab/Radiation Improves T Cell Infiltration in Early Breast Cancer

How Will ADCs Influence the Treatment Landscape in SCLC?

© 2025 MJH Life Sciences^®

All rights reserved.